Browse by:
| All Year | 2020 | 2019 | 2006 | 2007 | 2021 | 2022 |
KPJ Healthcare Heightens Groupwide Employees Surveillance Testing
KUALA LUMPUR, 9 December: KPJ Healthcare Berhad (“KPJ Healthcare”
or the “Company”), Malaysia’s largest
private healthcare provider, which has over 15,000 employees nationwide, is taking extra precautionary measures to minimise
the spread of COVID-19 at the workplace
which in turn would limit
disruptions to daily hospital operations by heightening its mandatory staff surveillance testing.
With still more than 4,000 of COVID-19 cases daily and the emergence of the new Omicron variant
in Malaysia, the Company has taken the proactive approach
of mandatory surveillance testing at the workplace
to monitor and address possible
future outbreaks.
“The private
sector has a critical role to play in ramping up voluntary screenings and
deploying mass COVID-19 testing is
essential, if economies are to reopen,” said Ahmad Shahizam Mohd Shariff,
President and Managing Director of KPJ Healthcare.
“Businesses will
need to quickly and accurately identify infections and make sure employees, contractors and suppliers are isolated in
order to ensure business continuity,” added Ahmad Shahizam.
The social and
economic challenges posed by COVID-19 have emphasised the true value of recognising and mitigating material risks.
As a responsible and conscientious organisation, the surveillance testing allows
for early identification of individuals infected
with COVID-19 who have developed an immune response, even if
they were asymptomatic. This will provide necessary protection for the Company’s employees and making sure its
hospitals are safe for patients to receive their
treatments.
To make it
seamless, the Company provides self-test kits for its employees and
subsequently they will need to upload the results
unto the ‘Surveillance Test Declaration’ centralised platform for further
analysis and monitoring.
Testing for COVID -19 remains a priority around the world as governments and health centres continue to study the coronavirus pandemic. Many patients who experience mild symptoms or no symptoms at all rarely get tested, which has prompted experts to suggest there may be a high number of unreported cases. Scaling up COVID-19 tests can provide a more accurate picture of the situation, significantly more than current levels to ensure that the workplace cluster can be minimised from spreading within the communities.